Clinical Trial Update: Assessment of the Clinical, Cellular and Molecular Effects of Royalactin-Royal Jelly on the Healing of Wagner Grad II Diabetic Foot Ulcers. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the clinical, cellular, and molecular effects of Royalactin-Royal Jelly on healing Wagner Grade II diabetic foot ulcers; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Royalactin-Royal Jelly (Royalactin)

Snippet

Sponsor: Universidad Autonoma de Nuevo Leon | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: COMPLETED